Carson Wealth (CWM LLC)
INDV icon

Carson Wealth (CWM LLC)’s Indivior Pharmaceuticals INDV Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$157K Sell
5,145
-3,857
-43% -$127K ﹤0.01% 2931
2025
Q4 		$323K Buy
9,002
+7,962
+766% +$243K ﹤0.01% 2209
2025
Q3 		$25K Buy
+1,040
New +$21.8K ﹤0.01% 3986

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Carson Wealth (CWM LLC)'s INDV Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Indivior Pharmaceuticals (INDV) stake by 43% in Q1 2026, selling an estimated $127K and leaving 5,145 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2931.

Carson Wealth (CWM LLC) first reported a position in INDV in Q3 2025 and has held it in 3 quarters since. The position peaked at $323K in Q4 2025. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Carson Wealth (CWM LLC) held 5,145 shares of Indivior Pharmaceuticals worth $157K as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 3,857 Indivior Pharmaceuticals shares in Q1 2026, an estimated $127K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #2931 holding.
  • Carson Wealth (CWM LLC) first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Carson Wealth (CWM LLC)'s Indivior Pharmaceuticals position peaked at $323K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.